Application for the first clinical trial of a prophylactic vaccine  against SARS-Cov-2 #covid19 entered in the backlog of CTA applications this week in France🇫🇷. Sponsoring of @institutpasteur. This is Themis / $MRK TMV-083 candidate using a measle vector. https://t.co/gePjSGKtYo